Track National Research Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

National Research Corporation NR1A.SG · Stock Open National Research Corporation in new tab

18.30 EUR
P/E
84.76
EPS
0.21
Yield
3.16%
P/B
69.72
ROE
42.03
Beta
0.38
Loading chart...
Key Metrics
P/E84.76
EPS0.21
Book Value0.26
Price to Book69.72
Debt/Equity1381.07
% Insiders49.788%
Growth
Revenue Growth0.04%
Earnings Growth-0.44%
Dividend
Dividend Yield3.16%
Annual dividends0.56 EUR
Ex-Div. DateJune 26, 2026
Payout250.00%
5y avg Yield2.12%

DCF Valuation

Tweak assumptions to recompute fair value for National Research Corporation (NR1A.SG)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

National Research Corporation Logo National Research Corporation Analysis (NR1A.SG)

United States Health Care Official Website Stock

Is National Research Corporation a good investment? National Research Corporation (NR1A.SG) is currently trading at 18.30 EUR.

In terms of valuation, the stock trades at a P/E ratio of 84.76. This high multiple suggests investors have priced in significant future growth expectations.

For income investors, National Research Corporation pays a dividend yield of 3.16%. With a payout ratio of 250%, the dividend appears to be under pressure.

Investor FAQ

Does National Research Corporation pay a dividend?

Yes, it pays an annual dividend of 0.56 EUR (3.16% yield).

What asset class is National Research Corporation?

National Research Corporation is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.

Company Profile

NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; and consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage. In addition, the company offers Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion; and governance solutions provided through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership. Further, it provides patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company was formerly known as National Research Corporation and changed its name to NRC Health April 2026. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.

Exchange Ticker
SET (Thailand) IRCP-R.BK
FRA (Germany) NRC.F
STU (Germany) NRC.SG
STU (Germany) NR1A.SG
NMS (United States) STIM
Trades
Dividend Yield
3.16%
5y avg 2.12%
Annual Dividends
0.56EUR
Next Ex. Div Date
June 26, 2026
Payout Ratio
250.00%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
0.27 EUR
June 29, 2027 (estimated) 0.1639
March 29, 2027 (estimated) 0.1032
2026
0.64 EUR
Dec. 28, 2026 (estimated) 0.1376
Sept. 28, 2026 (estimated) 0.2235
June 26, 2026 0.1405
March 27, 2026 0.1376
2025
0.45 EUR
Dec. 29, 2025 0.1376
Sept. 26, 2025 0.1032
June 27, 2025 0.1032
March 28, 2025 0.1032
2024
0.41 EUR
Dec. 27, 2024 0.1032
Sept. 27, 2024 0.1032
June 28, 2024 0.1032
March 27, 2024 0.1032
2023
1.27 EUR
Dec. 28, 2023 0.1032
Sept. 28, 2023 0.1032
Sept. 15, 2023 0.8597
June 29, 2023 0.1032
March 30, 2023 0.1032
2022
0.72 EUR
Dec. 29, 2022 0.1032
Sept. 29, 2022 0.2063
June 29, 2022 0.2063
March 30, 2022 0.2063
2021
0.41 EUR
Dec. 29, 2021 0.1032
Sept. 29, 2021 0.1032
June 29, 2021 0.1032
April 16, 2021 0.1032
2020
0.18 EUR
March 30, 2020 0.1805
2019
0.67 EUR
Dec. 30, 2019 0.1805
Sept. 27, 2019 0.1633
June 27, 2019 0.1633
March 28, 2019 0.1633
2018
0.97 EUR
Dec. 28, 2018 0.5932
Sept. 27, 2018 0.1461
June 28, 2018 0.1461
March 28, 2018 0.0860
2017
0.17 EUR
Dec. 28, 2017 0.0860
Sept. 28, 2017 0.0860
Upcoming Dividends
Name Payment Date Status Amount
National Research Corporation Jun 26, 2026 0.140464 EUR
National Research Corporation Mar 27, 2026 0.137552 EUR
National Research Corporation Dec 29, 2025 0.137552 EUR
National Research Corporation Sep 26, 2025 0.103164 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Community Discussion